跳至主要内容
临床试验/IRCT20220224054116N1
IRCT20220224054116N1招募中3 期

Effect of Qurs-e Tabasheer, a traditional Persian formula, on blood glucose and renal complications in patients with diabetic nephropathy, a randomized controlled trial

Alborz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • •Patients with diabetes and diabetic nephropathy
  • •Patients receiving a stable dose of ACEI or ARB
  • •eGFR between 15 and 30 (stage 4 CKD)
  • •Albuminuria more than 30 mg/day
  • •Patients over 18 years old

排除标准

  • •Patients with liver disease, active infection, malignancy
  • •Patients with kidney disease from nondiabetic cause
  • •Problems with nutrient absorption in gastrointestinal tract
  • •Sensitivity to drug components
  • •Pregnant or lactating women

研究者

发起方
Alborz University of Medical Sciences

相似试验